| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |